查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1235993

全球女性不育藥物市場規模調查和預測：按藥物、給藥途徑、分銷渠道和地區分析，2022-2029

Global Female Infertility Treatment Drugs Market Size study & Forecast, by Therapy by Route of Administration, by Distribution Channel and Regional Analysis, 2022-2029
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3個工作天內

價格

2021 年全球女性不育藥物市場價值約為 26.498 億美元，在 2022-2029 年預測期內以超過 4.3% 的健康增長率增長。我來了。

女性不孕症是指女性無法懷孕。 女性不育可能由多種因素引起，包括年齡、荷爾蒙失調、身體健康和生活方式選擇。 用於識別女性不孕症的測試包括卵巢儲備測試、子宮輸卵管造影和排卵測試。 由於全球不孕率上升和不孕症研發資金增加等因素，女性不孕不育藥物市場正在擴大。 然而，藥物治療的有效替代品和高藥價的存在可能會阻礙市場增長。

世界不孕率下降是推動市場增長的一個因素。 例如，根據世界銀行組織的數據，2017 年全球總和生育率（每位婦女的生育數）為 2.427，2019 年全球進一步下降至 2.402。 因此，這些下降表明不孕率上升正在推動市場增長。 此外，世界各地的新興市場正在為不孕症患者提供治療保險，藥物開發活動的增加正在推動市場的有利增長。

全球女性不育藥物市場研究考慮的主要區域是亞太地區、北美、歐洲、拉丁美洲和世界其他地區。 由於品牌產品的主導地位和該地區不斷上升的不孕率，北美在銷售方面佔據了市場主導地位。 另一方面，由於目標人群的增長、藥物開發研究合作的增加、主要公司的區域擴張以及政府機構和非機構的市場進入等因素，亞太地區在預測期內的複合年增長率將最高。利潤。預計增長

近期市場趨勢

  • 2020 年 1 月，Bayer AG宣布，專門從事女性健康的生物技術公司 Evotec SE 和許多其他治療多囊卵巢綜合徵 (PCOS) 的公司宣布了新的 5 年期，多囊卵巢綜合徵是導致女性不孕的原因之一，多目標研究合作開發臨床候選人
  • 2019 年 1 月，生物製藥公司 Ferring Pharmaceuticals 與印度跨國製藥公司 Sun Pharmaceutical Industries Ltd. 取得女性不孕不育藥物加尼瑞克醋酸鹽注射液仿製藥的美國商業化權利。簽署獨家收購協議

全球市場報告範圍

  • 歷史數據：2019-2020-2021
  • 估算基準年：2021 年
  • 預測期：2022-2029
  • 報告範圍：收入預測、公司排名、競爭格局、增長因素、趨勢
  • 按地區劃分：北美、歐洲、亞太地區、拉丁美洲、世界其他地區
  • 定制範圍：免費報告定制（最多 8 個工作小時）。 按國家、地區和部門劃分的範圍的添加和更改。

本研究的目的是弄清近年來各個領域和國家的市場規模，並對未來幾年的市場規模進行預測。 該報告旨在捕捉被調查國家工業的定性和定量方面的情況。

它還提供了關鍵方面的詳細信息，例如決定市場未來增長的驅動因素和挑戰。 此外，它還結合了利益相關者投資的潛在微觀市場機會，以及主要參與者的競爭格局等詳細分析。

內容

第 1 章執行摘要

  • 市場概況
  • 2019-2029 年各細分市場的全球市場估計和預測
    • 女性不育藥物市場，按地區劃分，2019-2029 年
    • 女性不育藥物市場，按藥物分類，2019-2029 年
    • 女性不育藥物市場，按給藥途徑，2019-2029 年
    • 女性不育藥物市場，按分銷渠道，2019-2029 年
  • 主要趨勢
  • 調查方法
  • 調查先決條件

第 2 章女性不育藥物全球市場的定義和範圍

  • 調查目的
  • 市場定義和範圍
    • 調查範圍
    • 工業發展
  • 本次調查涵蓋的年份
  • 貨幣兌換率

第3章女性不育藥物的全球市場動態

  • 女性不育藥物市場影響分析（2019-2029）
    • 市場驅動力
      • 世界上不孕症的增加
      • 擴大對不孕不育研究和開發的資助
    • 市場挑戰
      • 存在有效的藥物替代品
      • 高藥價
    • 市場機會
      • 世界各國政府提供的不孕不育治療保險等支持
      • 藥物開發活動的啟動

第四章全球女性不孕藥物市場行業分析

  • 波特 5 力模型
    • 供應商的議價能力
    • 買家的議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭公司之間的敵對關係
  • 波特 5 力模型的未來方法 (2019-2029)
  • 害蟲分析
    • 政治
    • 經濟的
    • 社交
    • 技術
  • 最佳投資機會
  • 關鍵成功策略
  • 業內人士的前景
  • 分析師的建議和結論

第 5 章風險評估：COVID-19 的影響

  • 評估 COVID-19 對行業的總體影響
  • COVID-19 之前和 COVID-19 之後的市場情景

第 6 章全球女性不育藥物市場：按藥物分類

  • 市場概況
  • 女性不育藥物的全球市場：按藥物、按性能 - 潛力分析
  • 2019-2029 年全球女性不育藥物市場、藥物估計和預測
  • 女性不育藥物市場，按細分市場分析
    • 促性腺激素
    • 克羅米酚
    • 來曲唑
    • 二甲雙胍
    • 醋酸亮丙瑞林
    • 其他

第 7 章全球女性不育藥物市場：按給藥途徑

  • 市場概況
  • 女性不育藥物的全球市場：按給藥途徑進行的性能潛力分析
  • 2019-2029 年女性不育藥物全球市場管理途徑的估計和預測
  • 女性不育藥物市場，按細分市場分析
    • 口語
    • 可注射

第 8 章全球女性不育藥物市場：按分銷渠道

  • 市場概況
  • 女性不育藥物的全球市場：按分銷渠道進行的性能潛力分析
  • 2019-2029 年全球女性不育藥物市場估計和預測（按分銷渠道）
  • 女性不育藥物市場，按細分市場分析
    • 醫院藥房
    • 零售藥房
    • 在線藥店

第 9 章全球女性不育藥物市場：區域分析

  • 女性不育藥物市場，按地區劃分的市場概況
  • 北美
    • 美國
      • 2019-2029 年各治療藥物的估計和預測
      • 按給藥途徑估算和預測，2019-2029 年
      • 2019-2029 年各分銷渠道的估計和預測
    • 加拿大
  • 歐洲女性不孕藥物市場概況
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 意大利
    • 其他歐洲
  • 亞太地區女性不育藥物市場概況
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 韓國
    • 其他亞太地區
  • 拉丁美洲女性不育藥物市場概況
    • 巴西
    • 墨西哥
    • 其他拉丁美洲地區
  • 世界其他地方

第 10 章衝突信息

  • 頂級市場策略
  • 公司簡介
    • Ferring Pharmaceuticals
      • 關鍵信息
      • 概覽
      • 財務（僅當數據可用時）
      • 產品概覽
      • 近期趨勢
    • Merck & Co, Inc.
    • Bayer AG
    • Abbott Laboratories
    • Par Pharmaceuticals
    • Sumitovant
    • Livzon
    • Zydus Cadila
    • Mankind Pharma
    • Oxolife

第 11 章研究過程

  • 研究過程
    • 數據挖掘
    • 分析
    • 市場評估
    • 驗證
    • 出版
  • 調查的特點
  • 調查先決條件

Global Female Infertility Treatment Drugs Market is valued approximately USD 2,649.8 million in 2021 and is anticipated to grow with a healthy growth rate of more than 4.3% over the forecast period 2022-2029. Female infertility is a condition where a woman is unable to conceive. Female infertility can be caused by several variables, including age, hormonal imbalance, physical health, and lifestyle choices. A few of the tests used to identify female infertility include ovarian reserve testing, hysterosalpingography, and ovulation testing. The Female Infertility Treatment Drugs market is expanding because of factors such as increasing infertility rates globally and increasing funding for infertility R&D. However, the presence of effective alternatives to medication, high cost of drugs may halt market growth.

Decline in prevalence of fertility rates across the globe is fostering the market growth. For instance, according to the World Bank Organisation, the total fertility rate (births per woman) was 2.427 in 2017, which was further decreased to 2.402 in 2019, globally. Thus these decline indicates the rise in infertility rates which is driving the marker growth. Furthermore, Governments worldwide to support to infertility patients by providing insurance coverage for treatment and rise in drug development activities is creating a lucrative growth to the market.

The key regions considered for the Global Female Infertility Treatment Drugs Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the dominance of branded products and the region's increasing infertility rate. Whereas Asia Pacific is expected to grow with a highest CAGR during the forecast period, owing to factors such as rising target populations, an increase in the number of collaborations for drug development, geographic expansion of key players, and active participation of government and nonprofit organizations in the market space.

Major market players included in this report are:

  • Ferring Pharmaceuticals
  • Merck & Co, Inc.
  • Bayer AG
  • Abbott Laboratories
  • Par Pharmaceuticals
  • Sumitovant
  • Livzon
  • Zydus Cadila
  • Mankind Pharma
  • Oxolife

Recent Developments in the Market:

  • In January 2020, Bayer AG announced a new five-year, multi-target collaboration with Evotec SE, a biotechnology company specialising in women's health, to develop a number of clinical candidates for the treatment of polycystic ovarian syndrome (PCOS), one of the factors contributing to female infertility.
  • In January 2019, Ferring Pharmaceuticals, a biopharmaceutical company, signed an exclusive agreement with Sun Pharmaceutical Industries Ltd., an Indian multinational pharmaceutical company, to acquire the U.S. commercialization rights for a generic version of Ganirelix Acetate Injection, which is used to treat female infertility.

Global Female Infertility Treatment Drugs Market Report Scope:

  • Historical Data: 2019-2020-2021
  • Base Year for Estimation: 2021
  • Forecast period: 2022-2029
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Therapy, Route of Administration, Distribution Channel, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Therapyofferings of key players. The detailed segments and sub-segment of the market are explained below:

By Therapy:

  • Gonadotropins
  • Clomiphene
  • Letrozole
  • Metformin
  • Leuprolide Acetate
  • Others

By Route of Administration:

  • Oral
  • Injectable

By Distribution Channel:

  • Hospitals Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • RoLA
  • Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Million)
    • 1.2.1. Female Infertility Treatment Drugs Market, by Region, 2019-2029 (USD Million)
    • 1.2.2. Female Infertility Treatment Drugs Market, by Therapy, 2019-2029 (USD Million)
    • 1.2.3. Female Infertility Treatment Drugs Market, by Route of Administration, 2019-2029 (USD Million)
    • 1.2.4. Female Infertility Treatment Drugs Market, by Distribution Channel, 2019-2029 (USD Million)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Female Infertility Treatment Drugs Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Female Infertility Treatment Drugs Market Dynamics

  • 3.1. Female Infertility Treatment Drugs Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing infertility rates globally
      • 3.1.1.2. Increasing funding for infertility R&D
    • 3.1.2. Market Challenges
      • 3.1.2.1. The presence of effective alternatives to medications
      • 3.1.2.2. High cost of Drugs
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Governments worldwide to support to infertility patients by providing insurance coverage for treatment.
      • 3.1.3.2. Rise in drug development activities

Chapter 4. Global Female Infertility Treatment Drugs Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. Industry Experts Prospective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Female Infertility Treatment Drugs Market, by Therapy

  • 6.1. Market Snapshot
  • 6.2. Global Female Infertility Treatment Drugs Market by Therapy, Performance - Potential Analysis
  • 6.3. Global Female Infertility Treatment Drugs Market Estimates & Forecasts by Therapy 2019-2029 (USD Million)
  • 6.4. Female Infertility Treatment Drugs Market, Sub Segment Analysis
    • 6.4.1. Gonadotropins
    • 6.4.2. Clomiphene
    • 6.4.3. Letrozole
    • 6.4.4. Metformin
    • 6.4.5. Leuprolide Acetate
    • 6.4.6. Others

Chapter 7. Global Female Infertility Treatment Drugs Market, by Route of Administration

  • 7.1. Market Snapshot
  • 7.2. Global Female Infertility Treatment Drugs Market by Route of Administration, Performance - Potential Analysis
  • 7.3. Global Female Infertility Treatment Drugs Market Estimates & Forecasts by Route of Administration 2019-2029 (USD Million)
  • 7.4. Female Infertility Treatment Drugs Market, Sub Segment Analysis
    • 7.4.1. Oral
    • 7.4.2. Injectable

Chapter 8. Global Female Infertility Treatment Drugs Market, by Distribution Channel

  • 8.1. Market Snapshot
  • 8.2. Global Female Infertility Treatment Drugs Market by Distribution Channel, Performance - Potential Analysis
  • 8.3. Global Female Infertility Treatment Drugs Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Million)
  • 8.4. Female Infertility Treatment Drugs Market, Sub Segment Analysis
    • 8.4.1. Hospitals Pharmacies
    • 8.4.2. Retail Pharmacies
    • 8.4.3. Online Pharmacies

Chapter 9. Global Female Infertility Treatment Drugs Market, Regional Analysis

  • 9.1. Female Infertility Treatment Drugs Market, Regional Market Snapshot
  • 9.2. North America Female Infertility Treatment Drugs Market
    • 9.2.1. U.S. Female Infertility Treatment Drugs Market
      • 9.2.1.1. Therapy breakdown estimates & forecasts, 2019-2029
      • 9.2.1.2. Route of Administration breakdown estimates & forecasts, 2019-2029
      • 9.2.1.3. Distribution Channel breakdown estimates & forecasts, 2019-2029
    • 9.2.2. Canada Female Infertility Treatment Drugs Market
  • 9.3. Europe Female Infertility Treatment Drugs Market Snapshot
    • 9.3.1. U.K. Female Infertility Treatment Drugs Market
    • 9.3.2. Germany Female Infertility Treatment Drugs Market
    • 9.3.3. France Female Infertility Treatment Drugs Market
    • 9.3.4. Spain Female Infertility Treatment Drugs Market
    • 9.3.5. Italy Female Infertility Treatment Drugs Market
    • 9.3.6. Rest of Europe Female Infertility Treatment Drugs Market
  • 9.4. Asia-Pacific Female Infertility Treatment Drugs Market Snapshot
    • 9.4.1. China Female Infertility Treatment Drugs Market
    • 9.4.2. India Female Infertility Treatment Drugs Market
    • 9.4.3. Japan Female Infertility Treatment Drugs Market
    • 9.4.4. Australia Female Infertility Treatment Drugs Market
    • 9.4.5. South Korea Female Infertility Treatment Drugs Market
    • 9.4.6. Rest of Asia Pacific Female Infertility Treatment Drugs Market
  • 9.5. Latin America Female Infertility Treatment Drugs Market Snapshot
    • 9.5.1. Brazil Female Infertility Treatment Drugs Market
    • 9.5.2. Mexico Female Infertility Treatment Drugs Market
    • 9.5.3. Rest of Latin America Female Infertility Treatment Drugs Market
  • 9.6. Rest of The World Female Infertility Treatment Drugs Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
    • 10.2.1. Ferring Pharmaceuticals
      • 10.2.1.1. Key Information
      • 10.2.1.2. Overview
      • 10.2.1.3. Financial (Subject to Data Availability)
      • 10.2.1.4. Product Summary
      • 10.2.1.5. Recent Developments
    • 10.2.2. Merck & Co, Inc.
    • 10.2.3. Bayer AG
    • 10.2.4. Abbott Laboratories
    • 10.2.5. Par Pharmaceuticals
    • 10.2.6. Sumitovant
    • 10.2.7. Livzon
    • 10.2.8. Zydus Cadila
    • 10.2.9. Mankind Pharma
    • 10.2.10. Oxolife

Chapter 11. Research Process

  • 11.1. Research Process
    • 11.1.1. Data Mining
    • 11.1.2. Analysis
    • 11.1.3. Market Estimation
    • 11.1.4. Validation
    • 11.1.5. Publishing
  • 11.2. Research Attributes
  • 11.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Female Infertility Treatment Drugs Market, report scope
  • TABLE 2. Global Female Infertility Treatment Drugs Market estimates & forecasts by Region 2019-2029 (USD Million)
  • TABLE 3. Global Female Infertility Treatment Drugs Market estimates & forecasts by Therapy 2019-2029 (USD Million)
  • TABLE 4. Global Female Infertility Treatment Drugs Market estimates & forecasts by Route of Administration 2019-2029 (USD Million)
  • TABLE 5. Global Female Infertility Treatment Drugs Market estimates & forecasts by Distribution Channel 2019-2029 (USD Million)
  • TABLE 6. Global Female Infertility Treatment Drugs Market estimates & forecasts by xyz 2019-2029 (USD Million)
  • TABLE 7. Global Female Infertility Treatment Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 8. Global Female Infertility Treatment Drugs Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 9. Global Female Infertility Treatment Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 10. Global Female Infertility Treatment Drugs Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 11. Global Female Infertility Treatment Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 12. Global Female Infertility Treatment Drugs Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 13. Global Female Infertility Treatment Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 14. Global Female Infertility Treatment Drugs Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 15. Global Female Infertility Treatment Drugs Market by segment, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 16. Global Female Infertility Treatment Drugs Market by region, estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 17. U.S. Female Infertility Treatment Drugs Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 18. U.S. Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 19. U.S. Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 20. Canada Female Infertility Treatment Drugs Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 21. Canada Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 22. Canada Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 23. UK Female Infertility Treatment Drugs Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 24. UK Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 25. UK Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 26. Germany Female Infertility Treatment Drugs Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 27. Germany Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 28. Germany Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 29. France Female Infertility Treatment Drugs Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 30. France Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 31. France Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 32. Italy Female Infertility Treatment Drugs Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 33. Italy Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 34. Italy Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 35. Spain Female Infertility Treatment Drugs Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 36. Spain Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 37. Spain Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 38. RoE Female Infertility Treatment Drugs Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 39. RoE Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 40. RoE Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 41. China Female Infertility Treatment Drugs Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 42. China Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 43. China Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 44. India Female Infertility Treatment Drugs Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 45. India Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 46. India Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 47. Japan Female Infertility Treatment Drugs Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 48. Japan Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 49. Japan Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 50. South Korea Female Infertility Treatment Drugs Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 51. South Korea Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 52. South Korea Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 53. Australia Female Infertility Treatment Drugs Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 54. Australia Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 55. Australia Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 56. RoAPAC Female Infertility Treatment Drugs Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 57. RoAPAC Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 58. RoAPAC Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 59. Brazil Female Infertility Treatment Drugs Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 60. Brazil Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 61. Brazil Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 62. Mexico Female Infertility Treatment Drugs Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 63. Mexico Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 64. Mexico Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 65. RoLA Female Infertility Treatment Drugs Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 66. RoLA Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 67. RoLA Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 68. Row Female Infertility Treatment Drugs Market estimates & forecasts, 2019-2029 (USD Million)
  • TABLE 69. Row Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 70. Row Female Infertility Treatment Drugs Market estimates & forecasts by segment 2019-2029 (USD Million)
  • TABLE 71. List of secondary sources, used in the study of global Female Infertility Treatment Drugs Market
  • TABLE 72. List of primary sources, used in the study of global Female Infertility Treatment Drugs Market
  • TABLE 73. Years considered for the study
  • TABLE 74. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Female Infertility Treatment Drugs Market, research methodology
  • FIG 2. Global Female Infertility Treatment Drugs Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Female Infertility Treatment Drugs Market, key trends 2021
  • FIG 5. Global Female Infertility Treatment Drugs Market, growth prospects 2022-2029
  • FIG 6. Global Female Infertility Treatment Drugs Market, porters 5 force model
  • FIG 7. Global Female Infertility Treatment Drugs Market, pest analysis
  • FIG 8. Global Female Infertility Treatment Drugs Market, value chain analysis
  • FIG 9. Global Female Infertility Treatment Drugs Market by segment, 2019 & 2029 (USD Million)
  • FIG 10. Global Female Infertility Treatment Drugs Market by segment, 2019 & 2029 (USD Million)
  • FIG 11. Global Female Infertility Treatment Drugs Market by segment, 2019 & 2029 (USD Million)
  • FIG 12. Global Female Infertility Treatment Drugs Market by segment, 2019 & 2029 (USD Million)
  • FIG 13. Global Female Infertility Treatment Drugs Market by segment, 2019 & 2029 (USD Million)
  • FIG 14. Global Female Infertility Treatment Drugs Market, regional snapshot 2019 & 2029
  • FIG 15. North America Female Infertility Treatment Drugs Market 2019 & 2029 (USD Million)
  • FIG 16. Europe Female Infertility Treatment Drugs Market 2019 & 2029 (USD Million)
  • FIG 17. Asia pacific Female Infertility Treatment Drugs Market 2019 & 2029 (USD Million)
  • FIG 18. Latin America Female Infertility Treatment Drugs Market 2019 & 2029 (USD Million)
  • FIG 19. Global Female Infertility Treatment Drugs Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable